Ventura County picks new Health Care Agency director
Barry Zimmerman, the chief deputy director of the Ventura County Health Care Agency, has been selected as the next director of the agency. Ventura County Executive Officer Mike Powers selected Zimmerman after a nationwide recruitment, the county said in a March 11 news release. Zimmerman, a longtime county manager, has been with the Health Care Read More →
Our View: Life science industry merits state support
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Gyms juggle indoor, outdoor operations as region reopens
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen to buy cancer treatment biotech firm for $1.9B
Thousand Oaks-based Amgen, one of the biggest biotech companies in the world, will get bigger with the $1.9 billion acquisition of Five Prime Therapeutics, a clinical-stage biotech company developing stomach cancer therapies. Amgen announced the acquisition March 4 and the deal is expected to close by the end of the second quarter of 2021. Under Read More →
Direct Relief launches new health equity fund with Scott’s $50M gift
MacKenzie Scott’s donation to Direct Relief equaled the largest in the organization’s history, at $50 million, and will go toward the Fund for Health Equity, a new project Direct Relief unveiled March 2. Scott announced in December that she was giving nearly $4.2 billion to 384 different charitable organizations in the United States. Direct Relief, Read More →
Opinion: Parkinson’s diagnosis holds lessons for coping with COVID-19
By Paul D. Witman I was recently diagnosed with Parkinson’s disease, a progressive, slow-moving disease that has no known cure. My father passed away 10 years ago from the same disease, so this diagnosis generated some deep thinking about how I would respond to it. Modern science has identified treatments for many of the symptoms, Read More →
MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback
MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →
